Drug Trial Radar · NCT04928144
Phase 1 Study of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects
Last checked: Nov 19, 2026Latest source record: Mar 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Jul 2, 2021
Primary completion
Sep 17, 2021
Study completion Sep 17, 2021
Sponsor
- Lead sponsor
- Sunhawk Vision Biotech, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 15 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single-center, open-label, first-in-human dose-escalation study of SHJ002 Ophthalmic Solution in children. (Part 1) Three (3) subjects will receive each concentration of SHJ002 for 3 days in an escalation design in one eye. (Part 2) A Group of 9 additional children will receive the highest tolerated concentration for 28 days.
Conditions
- Myopia
Interventions
SHJ - Low concentrationDrug
Topical ophthalmic
SHJ - Mid concentrationDrug
Topical ophthalmic
SHJ - High concentrationDrug
Topical ophthalmic
SHJ - Maximum toleratedDrug
SHJ - Maximum tolerated
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in best corrected visual acuityTime frame: 3 days (Part 1) and 28 days (Part 2)
- Incidence of Adverse EventsTime frame: 3 days (Part 1) and 28 days (Part 2)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.